ID

12940

Descrizione

Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase; ODM derived from: https://clinicaltrials.gov/show/NCT00003694

collegamento

https://clinicaltrials.gov/show/NCT00003694

Keywords

versioni (1)
  1. 07/01/16 07/01/16 -
Titolare del copyright

CC BY-NC 3.0

Caricato su

7 gennaio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Chronic Myelogenous Leukemia, BCR-ABL1 Positive NCT00003694

Inglese

Eligibility Chronic Myelogenous Leukemia, BCR-ABL1 Positive NCT00003694

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic diagnosis of chronic myelogenous leukemia (cml) in chronic phase; patients in either accelerated or blastic phases are not eligible; clonal cytogenetic evolution alone does not exclude patients
Descrizione

chronic myelogenous leukemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023473
patients must meet one or more of the following criteria:
Descrizione

inclusion criteria

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1512693
cytogenetically determined philadelphia chromosome (ph+)
Descrizione

philadelphia chromosome

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0031526
bcr/abl protein detectable by immunoblotting
Descrizione

bcr/abl protein

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004891
polymerase chain reaction (pcr) positive fusion transcripts for bcr/abl
Descrizione

fusion transcripts for bcr/abl

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004891
UMLS CUI [2]
C0032520
bcr/abl translocation present by fluorescence in situ hybridization (fish)
Descrizione

bcr/abl translocation present by fluorescence in situ hybridization (fish)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004891
UMLS CUI [2]
C0162789
registration within eight weeks of the diagnosis and confirmation of ph+ or bcr/abl+
Descrizione

registration within eight weeks of the diagnosis and confirmation of ph+ or bcr/abl+

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0031526
UMLS CUI [2]
C0004891
no more than eight weeks of prior hydroxyurea therapy
Descrizione

hydroxyurea

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0020402
no previous therapy with homoharringtonine (hht)
Descrizione

homoharringtonine

Tipo di dati

boolean

no prior treatment for cml with agents other than hydroxyurea; thus, prior treatment for cml with agents such as interferon, busulfan or cytarabine will render patients ineligible
Descrizione

no prior treatment for cml with agents other than hydroxyurea; thus, prior treatment for cml with agents such as interferon, busulfan or cytarabine will render patients ineligible

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0733470
UMLS CUI [2]
C0006463
UMLS CUI [3]
C0010711
must not be a candidate for an early allogeneic bone marrow transplant; potential transplant candidates must be counseled about alternative donor transplants and must decline that treatment option
Descrizione

allogeneic bone marrow transplant

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005961
ecog performance status 0-2
Descrizione

ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
non-pregnant and non-nursing; treatment under this protocol would expose an unborn child to significant risks; women and men of reproductive potential should agree to use an effective means of birth control
Descrizione

non-pregnant and non-nursing; treatment under this protocol would expose an unborn child to significant risks; women and men of reproductive potential should agree to use an effective means of birth control

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0700589
bilirubin =< x upper limit of normal
Descrizione

bilirubin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
creatinine =< 1.5 mg/dl
Descrizione

creatinine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
Ritorna all'inizio della pagina

Similar models

Eligibility Chronic Myelogenous Leukemia, BCR-ABL1 Positive NCT00003694

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
chronic myelogenous leukemia
Item
histologic diagnosis of chronic myelogenous leukemia (cml) in chronic phase; patients in either accelerated or blastic phases are not eligible; clonal cytogenetic evolution alone does not exclude patients
boolean
C0023473 (UMLS CUI [1])
inclusion criteria
Item
patients must meet one or more of the following criteria:
boolean
C1512693 (UMLS CUI [1])
philadelphia chromosome
Item
cytogenetically determined philadelphia chromosome (ph+)
boolean
C0031526 (UMLS CUI [1])
bcr/abl protein
Item
bcr/abl protein detectable by immunoblotting
boolean
C0004891 (UMLS CUI [1])
fusion transcripts for bcr/abl
Item
polymerase chain reaction (pcr) positive fusion transcripts for bcr/abl
boolean
C0004891 (UMLS CUI [1])
C0032520 (UMLS CUI [2])
bcr/abl translocation present by fluorescence in situ hybridization (fish)
Item
bcr/abl translocation present by fluorescence in situ hybridization (fish)
boolean
C0004891 (UMLS CUI [1])
C0162789 (UMLS CUI [2])
registration within eight weeks of the diagnosis and confirmation of ph+ or bcr/abl+
Item
registration within eight weeks of the diagnosis and confirmation of ph+ or bcr/abl+
boolean
C0031526 (UMLS CUI [1])
C0004891 (UMLS CUI [2])
hydroxyurea
Item
no more than eight weeks of prior hydroxyurea therapy
boolean
C0020402 (UMLS CUI [1])
homoharringtonine
Item
no previous therapy with homoharringtonine (hht)
boolean
no prior treatment for cml with agents other than hydroxyurea; thus, prior treatment for cml with agents such as interferon, busulfan or cytarabine will render patients ineligible
Item
no prior treatment for cml with agents other than hydroxyurea; thus, prior treatment for cml with agents such as interferon, busulfan or cytarabine will render patients ineligible
boolean
C0733470 (UMLS CUI [1])
C0006463 (UMLS CUI [2])
C0010711 (UMLS CUI [3])
allogeneic bone marrow transplant
Item
must not be a candidate for an early allogeneic bone marrow transplant; potential transplant candidates must be counseled about alternative donor transplants and must decline that treatment option
boolean
C0005961 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
non-pregnant and non-nursing; treatment under this protocol would expose an unborn child to significant risks; women and men of reproductive potential should agree to use an effective means of birth control
Item
non-pregnant and non-nursing; treatment under this protocol would expose an unborn child to significant risks; women and men of reproductive potential should agree to use an effective means of birth control
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
bilirubin
Item
bilirubin =< x upper limit of normal
boolean
C1278039 (UMLS CUI [1])
creatinine
Item
creatinine =< 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial